Accounts Payable

6 Months Ended

Jun. 30, 2014

Accounts Payable Disclosure [Abstract]

Accounts Payable

4. Accounts Payable

As of June 30, 2014, Current Liabilities included accounts payable of $78,915 comprised primarily of approximate amounts owed totaling $43,277 to the Company’s auditors for work on the annual audit, $15,250 owed to the Company’s drug substance manufacturer, $18,150 to suppliers of services used in the clinical trial and other miscellaneous items totaling $2,238. As of June 30, 2014 accounts payable related party consisted of $3,213 for current patent expenses for the License Agreement. By the first week of August 2014, the June 30, 2014 amounts included in accounts payable and accounts payable related party had been substantially paid. As of December 31, 2013, Current Liabilities included accounts payable $76,109, which amounts were subsequently paid in 2014.